Specialty Drugs: Better Outcomes, Lower Costs with VIVIO CEO Pramod John.

Pramod John is the CEO of VIVIO, a company that has built an autonomous solution that allows employers and other healthcare payers to take control over their specialty drug spend.   VIVIO is a Public Benefit Corporation that operates with a transparent business model.  Their only form of compensation is an administration fee allowing them to focus just on the question of cost benefit at the individual patient level. We’ll hear how VIVIO’s approach differs from that of the traditional PBM and the impact this approach has on both health outcomes and costs.

Show notes:  Suggested Books:  Talking To Strangers by Malcolm Gladwell; Uncaring: How The Culture Of Medicine Kills Doctors And Patients by Robert Pearl.